Brookfield Corp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-244,353
| Closed | -$17.5M | – | 152 |
|
|
2023
Q2 | $17.5M | Sell |
244,353
-79,122
| -24% | -$5.66M | 0.07% | 103 |
|
|
2023
Q1 | $22.5M | Buy |
323,475
+75,360
| +30% | +$5.23M | 0.09% | 89 |
|
|
2022
Q4 | $16.8M | Buy |
248,115
+111,868
| +82% | +$7.58M | 0.06% | 110 |
|
|
2022
Q3 | $7.47M | Buy |
136,247
+9,166
| +7% | +$503K | 0.03% | 209 |
|
|
2022
Q2 | $8.4M | Buy |
+127,081
| New | +$8.4M | 0.04% | 172 |
|
|
2022
Q1 | – | Sell |
-305,014
| Closed | -$17.8M | – | 605 |
|
|
2021
Q4 | $17.8M | Buy |
305,014
+177,849
| +140% | +$10.4M | 0.07% | 85 |
|
|
2021
Q3 | $7.64M | Buy |
127,165
+43,130
| +51% | +$2.59M | 0.03% | 168 |
|
|
2021
Q2 | $5.03M | Buy |
+84,035
| New | +$5.03M | 0.02% | 211 |
|